Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 2964-2973

  Cyktor, Joshua C ^a   Turner, Joanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; B LYMPHOCYTE; BACTERIAL LOAD; CANDIDIASIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EUKARYOTE; GENETIC VARIABILITY; HUMAN; IMMUNITY; IMMUNOMODULATION; INFECTION CONTROL; INFLAMMATION; INNATE IMMUNITY; LEISHMANIASIS; LISTERIOSIS; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; Q FEVER; REGULATORY T LYMPHOCYTE; SHORT SURVEY; TOXOPLASMOSIS; TUBERCULOSIS; VIRULENCE;

ANIMALS; BACTERIA; FUNGI; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; INTERLEUKIN-10; PARASITES;

EID: 79961102157     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00047-11     Document Type: Short Survey

References (137)

1. Ananieva, O., et al. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9, 1028-1036.
2. Araujo, F. F., et al. 2007. Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front. Biosci. 12, 2797-2806.
3. Beamer, G. L., et al. 2008. Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J. mice. J. Immunol. 181, 5545-5550.
4. Belkaid, Y., et al. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506.
5. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507.
6. Benoit, M., E. Ghigo, C. Capo, D. Raoult, and J. L. Mege. 2008. The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization, a model for Q fever endocarditis. PLoS Pathog. 4, e1000066.
7. Bliss, S. K., L. C. Gavrilescu, A. Alcaraz, and E. Y. Denkers. 2001. Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology. Infect. Immun. 69, 4898-4905.
8. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
9. Bourreau, E., et al. 2007. IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis. Microbes Infect. 9, 1034-1041.
10. Bourreau, E., et al. 2009. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect. Immun. 77, 1465-1474.
11. Bourreau, E., et al. 2009. In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment. J. Infect. Dis. 199, 576-579.
12. Boussiotis, V. A., et al. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105, 1317-1325.
13. Brown, C. Y., C. A. Lagnado, M. A. Vadas, and G. J. Goodall. 1996. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 271, 20108-20112.
14. Butcher, B. A., et al. 2005. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. J. Immunol. 174, 3148-3152.
15. Cao, S., J. Liu, L. Song, and X. Ma. 2005. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J. Immunol. 174, 3484-3492.
16. Chakravarty, S. D., et al. 2008. Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs. Infect. Immun. 76, 916-926.
17. Chandra, D., and S. Naik. 2008. Leishmania donovani infection downregulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol. 154, 224-234.
18. Chang, H. D., et al. 2007. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37, 807-817.
19. Chen, G., et al. 2009. Effects of CD4(+)CD25(+)Foxp3(+)regulatory T cells on early Plasmodium yoelii 17XL infection in BALB/c mice. Parasitology 136, 1107-1120.
20. Chen, X., et al. 2007. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123, 50-59.
21. Chiu, B. C., V. R. Stolberg, C. M. Freeman, and S. W. Chensue. 2007. Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice. Am. J. Pathol. 171, 829-837.
22. Chmiel, J. F., et al. 2002. Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice. Am. J. Respir. Crit. Care Med. 165, 1176-1181.
23. Clarencio, J., et al. 2006. Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites. Infect. Immun. 74, 4757-4765.
24. Dahl, K. E., H. Shiratsuchi, B. D. Hamilton, J. J. Ellner, and Z. Toossi. 1996. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64, 399-405.
25. Deepe, G. S., Jr., and R. S. Gibbons. 2003. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10. J. Immunol. 171, 5353-5362.
26. de la Barrera, S., et al. 2004. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138, 128-138.
27. Delgado, J. C., et al. 2002. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc. Natl. Acad. Sci. U. S. A. 99, 7576-7581.
28. Denis, M., and E. Ghadirian. 1993. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151, 5425-5430.
29. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes, an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
30. Dhingra, S., A. K. Sharma, R. C. Arora, J. Slezak, and P. K. Singal. 2009. IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc. Res. 82, 59-66.
31. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224-1234.
32. Ding, Y., et al. 2003. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170, 1383-1391.
33. Dorhoi, A., et al. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 207, 777-792.
34. Du, Z., et al. 2006. Selective regulation of IL-10 signaling and function by zymosan. J. Immunol. 176, 4785-4792.
35. Edwards-Smith, C. J., et al. 1999. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30, 526-530.
36. Erb, K. J., J. Kirman, B. Delahunt, W. Chen, and G. Le Gros. 1998. IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol. Cell Biol. 76, 41-46.
37. Feng, C. G., et al. 2002. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect. Immun. 70, 6672-6679.
38. Fitzgerald, D. C., et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379.
39. Florido, M., and R. Appelberg. 2006. Genetic control of immune-mediated necrosis of Mycobacterium avium granulomas. Immunology 118, 122-130.
40. Gallagher, P. M., et al. 2003. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58, 154-156.
41. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148, 1792-1796.
42. Gazzinelli, R. T., et al. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798-805.
43. Gehring, A. J., K. M. Dobos, J. T. Belisle, C. V. Harding, and W. H. Boom. 2004. Mycobacterium tuberculosis LprG (Rv1411c), a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 173, 2660-2668.
44. Geng, Y., et al. 2000. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J. Immunol. 164, 5522-5529.
45. Geurtsen, J., et al. 2009. Identification of mycobacterial alpha-glucan as a novel ligand for DC-SIGN, involvement of mycobacterial capsular polysaccharides in host immune modulation. J. Immunol. 183, 5221-5231.
46. Ghalib, H. W., et al. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92, 324-329.
47. Ghigo, E., C. Capo, D. Raoult, and J. L. Mege. 2001. Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation, role in microbicidal defect of Q. fever. Infect. Immun. 69, 2345-2352.
48. Groux, H., et al. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162, 1723-1729.
49. Guichelaar, T., et al. 2008. Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J. Immunol. 180, 1373-1381.
50. Hagenbaugh, A., et al. 1997. Altered immune responses in interleukin 10 transgenic mice. J. Exp. Med. 185, 2101-2110.
51. Harding, C. V., and W. H. Boom. 2010. Regulation of antigen presentation by Mycobacterium tuberculosis, a role for Toll-like receptors. Nat. Rev. Microbiol. 8, 296-307.
52. Higgins, D. M., et al. 2009. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb.) 89, 149-157.
53. Hoerauf, A., W. Solbach, M. Lohoff, and M. Rollinghoff. 1994. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int. Immunol. 6, 1117-1124.
54. Holscher, C., et al. 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 68, 4075-4083.
55. Hunter, C. A., et al. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316.
56. Im, S. H., A. Hueber, S. Monticelli, K. H. Kang, and A. Rao. 2004. Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 279, 46818-46825.
57. Jacobs, M., N. Brown, N. Allie, R. Gulert, and B. Ryffel. 2000. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 100, 494-501.
58. Jacobs, M., L. Fick, N. Allie, N. Brown, and B. Ryffel. 2002. Enhanced immune response in Mycobacterium bovis bacille Calmette Guerin (BCG)-infected IL-10-deficient mice. Clin. Chem. Lab. Med. 40, 893-902.
59. Jankovic, D., D. G. Kugler, and A. Sher. 2010. IL-10 production by CD4+ effector T cells, a mechanism for self-regulation. Mucosal Immunol. 3, 239-246.
60. Jankovic, D., et al. 2007. Conventional T-bet(+)Foxp3(+) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283.
61. Jones, E. A., and R. A. Flavell. 2005. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J. Immunol. 175, 7437-7446.
62. Joyce, D. A., and J. H. Steer. 1996. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNFalpha and TNF receptor release by cultured human monocytes. Cytokine 8, 49-57.
63. Junqueira-Kipnis, A. P., et al. 2005. Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis. Immunology 115, 246-252.
64. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166, 1141-1147.
65. Keane, J., H. G. Remold, and H. Kornfeld. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164, 2016-2020.
66. Kingo, K., S. Koks, H. Silm, and E. Vasar. 2003. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun. 4, 455-457.
67. Kinjyo, I., et al. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203, 1021-1031.
68. Kishore, R., J. M. Tebo, M. Kolosov, and T. A. Hamilton. 1999. Cutting edge, clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162, 2457-2461.
69. Kotenko, S. V., et al. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16, 5894-5903.
70. Kursar, M., et al. 2007. Cutting edge, regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661-2665.
71. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246.
72. Leng, J., B. A. Butcher, C. E. Egan, D. S. Abdallah, and E. Y. Denkers. 2009. Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. J. Immunol. 182, 489-497.
73. Leng, J., and E. Y. Denkers. 2009. Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages. PLoS One 4, e7589.
74. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67, 4435-4442.
75. Li, L., and C. Y. Wu. 2008. CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6. Blood 111, 5629-5636.
76. Macatonia, S. E., T. M. Doherty, S. C. Knight, and A. O'Garra. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150, 3755-3765.
77. Madan, R., et al. 2009. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312-2320.
78. McGeachy, M. J., et al. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397.
79. McPhee, J. B., P. Mena, and J. B. Bliska. 2010. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infect. Immun. 78, 3529-3539.
80. Medina, E., and R. J. North. 1998. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 93, 270-274.
81. Meghari, S., Y. Bechah, C. Capo, H. Lepidi, D. Raoult, P. J. Murray, and J. L. Mege. 2008. Persistent Coxiella burnetii infection in mice overexpressing IL-10, an efficient model for chronic Q fever pathogenesis. PLoS Pathog. 4, e23.
82. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
83. Murray, P. J., L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158, 315-321.
84. Murugaiyan, G., A. Mittal, R. Lopez-Diego, L. M. Maier, D. E. Anderson, and H. L. Weiner. 2009. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 183, 2435-2443.
85. Naicker, D. D., L. Werner, E. Kormuth, J. A. Passmore, K. Mlisana, S. A. Karim, and T. Ndung'u. 2009. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J. Infect. Dis. 200, 448-452.
86. Nair, S., et al. 2009. The PPE18 of Mycobacterium tuberculosis interacts with TLR2 and activates IL-10 induction in macrophage. J. Immunol. 183, 6269-6281.
87. Nemeth, Z. H., et al. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J. Immunol. 175, 8260-8270.
88. Netea, M. G., et al. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718.
89. North, R. J. 1998. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin. Exp. Immunol. 113, 55-58.
90. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms, evidence for Stat3-dependent and -independent pathways. EMBO J. 17, 1006-1018.
91. O'Garra, A., et al. 1990. Production of cytokines by mouse B cells, B lymphomas and normal B cells produce interleukin 10. Int. Immunol. 2, 821-832.
92. Ohman, H., et al. 2006. IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun. 7, 243-249.
93. Okwor, I., D. Liu, S. M. Beverley, and J. E. Uzonna. 2009. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process. Proc. Natl. Acad. Sci. U. S. A. 106, 13951-13956.
94. Okwor, I., and J. Uzonna. 2008. Persistent parasites and immunologic memory in cutaneous leishmaniasis, implications for vaccine designs and vaccination strategies. Immunol. Res. 41, 123-136.
95. Oldenhove, G., et al. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31, 772-786.
96. O'Leary, S., M. P. O'Sullivan, and J. Keane. 2010. IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. [Epub ahead of print.] doi, 10.1165/romb.2010-03190C.
97. Ozeki, Y., et al. 2010. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int. Immunol. 22, 179-189.
98. Paladino, N., et al. 2006. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J. Virol. 80, 9144-9150.
99. Patel, N. R., K. Swan, X. Li, S. D. Tachado, and H. Koziel. 2009. Impaired M. tuberculosis-mediated apoptosis in alveolar macrophages from HIV+ persons, potential role of IL-10 and BCL-3. J. Leukoc. Biol. 86, 53-60.
100. Penttila, T., et al. 2008. Chlamydia pneumoniae infection in IL-10 knock out mice, accelerated clearance but severe pulmonary inflammatory response. Microb. Pathog. 45, 25-29.
101. Perona-Wright, G., et al. 2009. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6, 503-512.
102. Philipovskiy, A. V., et al. 2005. Antibody against V antigen prevents Yopdependent growth of Yersinia pestis. Infect. Immun. 73, 1532-1542.
103. Powell, M. J., S. A. Thompson, Y. Tone, H. Waldmann, and M. Tone. 2000. Posttranscriptional regulation of IL-10 gene expression through sequences in the 3'-untranslated region. J. Immunol. 165, 292-296.
104. Qasimi, P., et al. 2006. Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages. J. Biol. Chem. 281, 6316-6324.
105. Redford, P. S., A. Boonstra, S. Read, J. Pitt, C. Graham, E. Stavropoulos, G. J. Bancroft, and A. O'Garra. 2010. Enhanced protecion to Mycobacterium tuberculosis in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 40, 2200-2210.
106. Reithmeier-Rost, D., S. Bierschenk, N. Filippova, J. Schroder-Braunstein, and A. Sing. 2004. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cell Immunol. 231, 63-74.
107. Riley, J. K., K. Takeda, S. Akira, and R. D. Schreiber. 1999. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274, 16513-16521.
108. Riyazi, N., et al. 2005. The role of interleukin 10 promoter polymorphisms in the susceptibility of distal interphalangeal osteoarthritis. J. Rheumatol. 32, 1571-1575.
109. Rocha-Ramirez, L. M., et al. 2008. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb.) 88, 212-220.
110. Rogers, N. C., et al. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507-517.
111. Romani, L., et al. 1997. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158, 5349-5356.
112. Romani, L., et al. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152, 3514-3521.
113. Ronet, C., et al. 2010. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 184, 886-894.
114. Ryter, S. W., L. E. Otterbein, D. Morse, and A. M. Choi. 2002. Heme oxygenase/carbon monoxide signaling pathways, regulation and functional significance. Mol. Cell. Biochem. 234-235, 249-263.
115. Sakaguchi, S., et al. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells, their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32.
116. Saraiva, M., et al. 2005. Identification of a macrophage-specific chromatin signature in the IL-10 locus. J. Immunol. 175, 1041-1046.
117. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181.
118. Sasaki, A., et al. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4, 339-351.
119. Schreiber, T., et al. 2009. Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J. Immunol. 183, 1301-1312.
120. Shafiani, S., G. Tucker-Heard, A. Kariyone, K. Takatsu, and K. B. Urdahl. 2010. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207, 1409-1420.
121. Shaler, C. R., et al. 2011. Pulmonary mycobacterial granuloma increased IL-10 production contributes to establishing a symbiotic host-microbe microenvironment. Am. J. Pathol. 178, 1622-1634.
122. Sharma, A., et al. 2009. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc. Natl. Acad. Sci. U. S. A. 106, 5761-5766.
123. Shoemaker, J., M. Saraiva, and A. O'Garra. 2006. GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells. J. Immunol. 176, 3470-3479.
124. Sing, A., A. Roggenkamp, A. M. Geiger, and J. Heesemann. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigeninduced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168, 1315-1321.
125. Sing, A., et al. 2002. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196, 1017-1024.
126. Spencer, S. D., et al. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187, 571-578.
127. Stumhofer, J. S., et al. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371.
128. Torrelles, J. B., and L. S. Schlesinger. 2010. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb.) 90, 84-93.
129. Turner, J., et al. 2002. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 169, 6343-6351.
130. Vazquez-Torres, A., J. Jones-Carson, R. D. Wagner, T. Warner, and E. Balish. 1999. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 67, 670-674.
131. Viana da Costa, A., et al. 2002. IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol. Int. 51, 367-379.
132. Vogt, J., C. D. Alba Soto, M. P. Mincz, and G. A. Mirkin. 2008. Impaired Trypanosoma cruzi-specific IFN-gamma secretion by T cells bearing the BV9 T-cell receptor is associated with local IL-10 production in nonlymphoid tissues of chronically infected mice. Microbes Infect. 10, 781-790.
133. Wang, Z. Y., et al. 2005. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J. Immunol. 174, 2098-2105.
134. Wieland, C. W., et al. 2007. Mice lacking SIGNR1 have stronger T helper 1 responses to Mycobacterium tuberculosis. Microbes Infect. 9, 134-141.
135. Willment, J. A., et al. 2003. Dectin-1 expression and function are enhanced on alternatively activated and GM-CSF-treated macrophages and are negatively regulated by IL-10, dexamethasone, and lipopolysaccharide. J. Immunol. 171, 4569-4573.
136. Yang, X., J. Gartner, L. Zhu, S. Wang, and R. C. Brunham. 1999. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J. Immunol. 162, 1010-1017.
137. Zheng, W., et al. 2010. Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice. Parasite Immunol. 32, 324-334.